Investor worries over Zhejiang Tianyu Pharmaceutical's slowi...

Moomoo AI Jan 7, 2024 09:16

Investor worries over Zhejiang Tianyu Pharmaceutical's slowing revenue could explain its low P/S ratio. The company needs notable financial uplift to justify ratio increase. Its lackluster future prospects compared to industry may clarify its current P/S status.

Insufficient Growth At Zhejiang Tianyu Pharmaceutical Co., Ltd. (SZSE:300702) Hampers Share Price

Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more

Translate

Report

1170 Views

Comment

Moomoo AI

Moomoo AI Official Account

Your AI assistant for discovering investment opportunities.

4952

Followers

Following

11K

Visitors